BIMI International Medical Inc. (BIMI)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 17.28 Million USD | -6.3% |
| 2021 | 12.7 Million USD | 103.09% |
| 2020 | 6.25 Million USD | 299.19% |
| 2019 | 1.56 Million USD | -90.36% |
| 2018 | 16.25 Million USD | 669.71% |
| 2017 | 2.11 Million USD | 29.64% |
| 2016 | 1.62 Million USD | -10.42% |
| 2015 | 1.81 Million USD | -2.27% |
| 2014 | 1.86 Million USD | 60.86% |
| 2013 | 1.15 Million USD | -9.55% |
| 2012 | 1.27 Million USD | -12.06% |
| 2011 | 1.45 Million USD | 17.78% |
| 2010 | 1.23 Million USD | 8.46% |
| 2009 | 1.13 Million USD | 23.48% |
| 2008 | 921.88 Thousand USD | -30.09% |
| 2007 | 1.31 Million USD | 384.55% |
| 2006 | 272.15 Thousand USD | -21.99% |
| 2005 | 348.86 Thousand USD | 11.29% |
| 2004 | 313.46 Thousand USD | 8.87% |
| 2003 | 287.91 Thousand USD | -12.08% |
| 2002 | 327.47 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 1.1 Million USD | 477.67% |
| 2023 Q2 | 1.58 Million USD | 42.82% |
| 2023 Q3 | 3.26 Million USD | 106.03% |
| 2022 Q4 | -293.77 Thousand USD | -106.28% |
| 2022 FY | 11.9 Million USD | -6.3% |
| 2022 Q3 | 4.67 Million USD | 44.38% |
| 2022 Q1 | 4.01 Million USD | 26.22% |
| 2022 Q2 | 3.23 Million USD | -19.32% |
| 2021 Q2 | 2.11 Million USD | -44.81% |
| 2021 Q1 | 3.83 Million USD | 1266.4% |
| 2021 FY | 12.7 Million USD | 103.09% |
| 2021 Q3 | 3.57 Million USD | 68.98% |
| 2021 Q4 | 3.18 Million USD | -11.01% |
| 2020 Q1 | 1.75 Million USD | 4390.15% |
| 2020 Q3 | 1.68 Million USD | -42.18% |
| 2020 Q4 | -328.58 Thousand USD | -119.44% |
| 2020 FY | 6.25 Million USD | 299.19% |
| 2020 Q2 | 2.92 Million USD | 66.88% |
| 2019 Q1 | 521.51 Thousand USD | -96.16% |
| 2019 FY | 1.56 Million USD | -90.36% |
| 2019 Q4 | -40.82 Thousand USD | -111.36% |
| 2019 Q3 | 359.3 Thousand USD | -50.57% |
| 2019 Q2 | 726.94 Thousand USD | 39.39% |
| 2018 FY | 16.25 Million USD | 669.71% |
| 2018 Q1 | 448.13 Thousand USD | -44.31% |
| 2018 Q2 | 1.83 Million USD | 309.58% |
| 2018 Q3 | 370.7 Thousand USD | -79.8% |
| 2018 Q4 | 13.59 Million USD | 3568.39% |
| 2017 FY | 2.11 Million USD | 29.64% |
| 2017 Q2 | 456.07 Thousand USD | -2.66% |
| 2017 Q1 | 468.53 Thousand USD | -48.81% |
| 2017 Q3 | 382.28 Thousand USD | -16.18% |
| 2017 Q4 | 804.69 Thousand USD | 110.49% |
| 2016 Q2 | 250.16 Thousand USD | -18.71% |
| 2016 FY | 1.62 Million USD | -10.42% |
| 2016 Q1 | 307.73 Thousand USD | -65.36% |
| 2016 Q4 | 915.31 Thousand USD | 488.24% |
| 2016 Q3 | 155.6 Thousand USD | -37.8% |
| 2015 Q1 | 282.3 Thousand USD | -56.43% |
| 2015 Q3 | 291.67 Thousand USD | -18.08% |
| 2015 FY | 1.81 Million USD | -2.27% |
| 2015 Q4 | 888.25 Thousand USD | 204.54% |
| 2015 Q2 | 356.04 Thousand USD | 26.12% |
| 2014 Q1 | 410.56 Thousand USD | -4.45% |
| 2014 FY | 1.86 Million USD | 60.86% |
| 2014 Q2 | 397.04 Thousand USD | -3.29% |
| 2014 Q4 | 648 Thousand USD | 60.05% |
| 2014 Q3 | 404.86 Thousand USD | 1.97% |
| 2013 Q2 | 257.44 Thousand USD | -17.77% |
| 2013 Q3 | 156.36 Thousand USD | -39.26% |
| 2013 Q4 | 429.7 Thousand USD | 174.81% |
| 2013 Q1 | 313.08 Thousand USD | -39.94% |
| 2013 FY | 1.15 Million USD | -9.55% |
| 2012 Q3 | 201.44 Thousand USD | -28.1% |
| 2012 FY | 1.27 Million USD | -12.06% |
| 2012 Q4 | 521.26 Thousand USD | 158.76% |
| 2012 Q1 | 275.85 Thousand USD | -22.9% |
| 2012 Q2 | 280.17 Thousand USD | 1.57% |
| 2011 Q3 | 325.03 Thousand USD | -26.73% |
| 2011 Q1 | 327.75 Thousand USD | -38.35% |
| 2011 FY | 1.45 Million USD | 17.78% |
| 2011 Q4 | 357.76 Thousand USD | 10.07% |
| 2011 Q2 | 443.6 Thousand USD | 35.35% |
| 2010 FY | 1.23 Million USD | 8.46% |
| 2010 Q1 | 172.48 Thousand USD | 15.28% |
| 2010 Q2 | 213.67 Thousand USD | 23.88% |
| 2010 Q3 | 316.75 Thousand USD | 48.24% |
| 2010 Q4 | 531.67 Thousand USD | 67.85% |
| 2009 Q1 | 194.01 Thousand USD | -42.3% |
| 2009 Q2 | 568.68 Thousand USD | 193.11% |
| 2009 Q3 | 225.99 Thousand USD | -60.26% |
| 2009 Q4 | 149.61 Thousand USD | -33.8% |
| 2009 FY | 1.13 Million USD | 23.48% |
| 2008 Q1 | 180.11 Thousand USD | -3.08% |
| 2008 Q4 | 336.23 Thousand USD | 86.84% |
| 2008 Q3 | 179.95 Thousand USD | -14.13% |
| 2008 Q2 | 209.57 Thousand USD | 16.36% |
| 2008 FY | 921.88 Thousand USD | -30.09% |
| 2007 Q4 | 185.83 Thousand USD | 24.67% |
| 2007 Q2 | 671.37 Thousand USD | 114.86% |
| 2007 Q1 | 312.47 Thousand USD | 306.67% |
| 2007 FY | 1.31 Million USD | 384.55% |
| 2007 Q3 | 149.06 Thousand USD | -77.8% |
| 2006 Q2 | 72.24 Thousand USD | -15.94% |
| 2006 Q3 | 256.16 Thousand USD | 254.57% |
| 2006 Q4 | -151.19 Thousand USD | -159.02% |
| 2006 FY | 272.15 Thousand USD | -21.99% |
| 2006 Q1 | 85.94 Thousand USD | 340.32% |
| 2005 Q4 | 19.51 Thousand USD | -85.79% |
| 2005 FY | 348.86 Thousand USD | 11.29% |
| 2005 Q3 | 137.31 Thousand USD | 61.13% |
| 2005 Q1 | 82.8 Thousand USD | -5.13% |
| 2005 Q2 | 85.22 Thousand USD | 2.92% |
| 2004 Q3 | 93.4 Thousand USD | 17.68% |
| 2004 Q1 | 53.4 Thousand USD | -38.51% |
| 2004 Q2 | 79.37 Thousand USD | 48.63% |
| 2004 FY | 313.46 Thousand USD | 8.87% |
| 2004 Q4 | 87.28 Thousand USD | -6.56% |
| 2003 FY | 287.91 Thousand USD | -12.08% |
| 2003 Q4 | 86.85 Thousand USD | 77.75% |
| 2003 Q3 | 48.86 Thousand USD | -51.56% |
| 2003 Q1 | 2342.00 USD | -97.5% |
| 2003 Q2 | 100.87 Thousand USD | 4207.17% |
| 2002 Q2 | 77.91 Thousand USD | 4253.02% |
| 2002 FY | 327.47 Thousand USD | 0.0% |
| 2002 Q3 | 53.47 Thousand USD | -31.38% |
| 2002 Q1 | 1790.00 USD | 0.0% |
| 2002 Q4 | 93.66 Thousand USD | 75.17% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 13.47 Million USD | -28.276% |
| China Jo-Jo Drugstores, Inc. | 34.64 Million USD | 50.096% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 89.97 Million USD | 80.785% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.12 Million USD | 80.817% |
| Leafly Holdings, Inc. | 44.5 Million USD | 61.151% |
| Leafly Holdings, Inc. | 44.5 Million USD | 61.151% |
| LifeMD, Inc. | 148.13 Million USD | 88.329% |
| LifeMD, Inc. | 148.13 Million USD | 88.329% |
| TRxADE HEALTH, Inc. | 9.86 Million USD | -75.309% |
| PetMed Express, Inc. | 86.81 Million USD | 80.085% |
| Walgreens Boots Alliance, Inc. | 40.6 Billion USD | 99.957% |